Irene Boo
Research Assistant, Drummer/Poumbourios Laboratory
Working groups
Qualifications
- BBiomedSc (Hons)
Burnet publications
View 29 more
16 Jul 2024
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
npj Vaccines
Gemma E. Hartley et al
Open access
10 Apr 2024
B-cell characteristics define HCV reinfection outcome
Journal of Hepatology
Alexander P. Underwood et al
Open access
14 Feb 2024
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy
Frontiers in Immunology
Anna C. Hearps et al
Open access
Current projects
Open to students
Development of a HCV vaccine candidate
No hepatitis C vaccine exists due to the virus's genetic diversity, a critical gap in global health. We aim to develop a vaccine that overcomes these hurdles.
Profiling immune responses in paediatric and high-risk populations to the COVID-19 virus (PROPHECY)
This study will evaluate immune responses after COVID-19 infection or vaccination in healthy and vulnerable people.